摘要:
The present invention relates to a method of increasing replication of a reassortant influenza virus by at least 10%, the method comprising the steps of: i) comparing the amino acid sequence of the reassortant influenza virus with the amino acid sequence of a different influenza virus, which different influenza virus grows in embryonated eggs; and ii) substituting as needed HA H3 amino acid residues such that position 186 is a valine and position 226 is an isoleucine. The present invention further relates to a replication enhanced reassortant influenza virus comprising an HA H3 protein comprising a valine at position 186 and an isoleucine at position 226. Furthermore, the invention relates to an immunogenic composition comprising the replication enhanced reassortant influenza virus comprising an HA H3 protein comprising a valine at position 186 and an isoleucine at position 226.
摘要:
Method of producing a temperature sensitive (ts) influenza virus, the method comprising:(a) introducing at least one mutation resulting in an amino acid substitution at a position selected from the group consisting of: PA431 ; PB2630; PA497 ; NP55 ; NP114 ;NP 410; NP 5 °9 ; M1159 and M1183 into an influenza B virus genome; and (b) replicating the mutated influenza virus genome under conditions whereby virus is produced.
摘要:
The present invention relates to genetically engineered recombinant RS viruses and viral vectors which contain heterologous genes which for the use as vaccines. In accordance with the present invention, the recombinant RS viral vectors and viruses are engineered to contain heterologous genes, including genes of other viruses, pathogens, cellular genes, tumor antigens, or to encode combinations of genes from different strains of RSV.
摘要:
The present invention encompasses methods of producing influenza B viruses in cell culture. The influenza B viruses may have desirable characteristics, such as enhanced replication in eggs and may be used, for example, in vaccines and in methods of treatment to protect against influenza B virus infection.
摘要:
The present invention relates to genetically engineered recombinant RS viruses and viral vectors which contain heterologous genes which for the use as vaccines. In accordance with the present invention, the recombinant RS viral vectors and viruses are enginnerred to contain heterologous genes, including genes of other viruses, pathogens, cellular genes, tumor antigens, or to encode combinations of genes from different strains of RSV.